These observations suggested that diabetes generates ER stress in osteoblasts that is dependent on Ca2+ homeostasis; moreover, cinaciguat relieved intracellular calcium overload and ER stress via PKG2 by suppressing PLCβ1, providing a novel pharmaceutical target for cinaciguat. Here, PRKG2 is linked to diabetes mellitus.